期刊文献+

猪Ⅱ型胶原及胶原肽抗关节炎的研究 被引量:5

Mechanism of Porcine Collagen Type Ⅱ and Collagen Peptide on Anti-arthritis
原文传递
导出
摘要 本实验以猪鼻骨为原料,采用盐析法提取天然Ⅱ型胶原蛋白,采用碱性蛋白酶酶解制备胶原肽,并测定胶原蛋白的纯度,分析胶原蛋白及胶原肽的理化性质。通过构建小鼠CIA动物模型,研究Ⅱ型胶原蛋白及胶原肽对类风湿性关节炎的作用效果。结果表明,提取所得蛋白的胶原蛋白含量为82.86%,在紫外波长230 nm下有最大吸收峰,280 nm处几乎无吸收峰,分子量大于300 KD,具备天然Ⅱ型胶原蛋白特征;酶解得胶原肽不含Ⅱ型胶原蛋白,分子量小于20 KD;Ⅱ型胶原蛋白能够降低小鼠关节指数、降低关节变形率,明显降低小鼠血清中IL-17、MMP-3和TNF-α水平(p<0.05),并能显著提高T细胞刺激指数(P<0.05),对B细胞刺激指数无明显效果(p>0.05);组织病理学显示Ⅱ型胶原蛋白能够减轻关节破坏程度,抑制软骨退化;而胶原肽不具有以上作用。 Collagen was extracted from pig cartilage by salting out, and collagen peptide was hydrolyzed by alkaline protease. Collagen purity and the physicochemical properties of collagen and peptide were analyzed. The effect of anti-arthritic was studied by constructing CIA model. 82.86% of collagen was obtained, with molecular weight of more than 300 KD.The maximum absorption peak of UV was at 230 nm, and no obvious absorption peak was observed at 280 nm. Therefore the extracted collagen possessed the characteristics of natural collagen type Ⅱ, while the molecular weight of collagen peptide was less than 20 KD and no collagen type Ⅱ was observed. Collagen type Ⅱ could reduce index score and joint deformation rate, and significantly reduce IL-17, MMP-3 and TNF-α levels. In addition, Collagen type Ⅱ could significantly increase the T cell stimulation index (P〈0.05), but had no effect on B cell stimulation index (p〉0.05). Tissue sections showed that Collagen type Ⅱ could'reduce destruction of joint and inhibit cartilage degradation. However, no such funcions were found with collagen peptide.
出处 《现代食品科技》 EI CAS 北大核心 2014年第3期1-6,共6页 Modern Food Science and Technology
关键词 Ⅱ型胶原蛋白 胶原肽 类风湿性关节炎 IL-17 MMP-3 TNF—α 淋巴细胞 collagen type Ⅱ collagen peptide rheumatoid arthritis IL-17 MMP-3 TNF-α immune cell
  • 相关文献

参考文献14

  • 1张义浜,刘志敏,熊凌霜.类风湿关节炎发病机制及其治疗方法研究进展[J].细胞与分子免疫学杂志,2005,21(B03):88-90. 被引量:65
  • 2Ruderman E M. Current and future pharmaceutical therapy for rheumatoid arthritis [J]. Current pharmaceutical design, 2005, 11(5): 671-684.
  • 3Hider S L, Buckley C, Silman A J, et al. Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis [J]. J. Rheumatol, 2005, 32(1): 11-16.
  • 4Barnett M L, Combitchi D, Trentham D E. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis [J]. Arthritis & Rheumatism, 1996, 39(4): 623-628.
  • 5Schellekens GA, Visser H, De-Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies reocognizing a cyclic citrullinated peptide [J]. Arthritis Rheum, 2000, 43: 155-163.
  • 6Cook A D, Rowley M J, Mackay I R, et al. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression [J]. Arthritis & Rheumatism, 1996, 39(10) 1720-1727.
  • 7段宙位,申铉日,陈秀明,王章晗.罗非鱼尾胶原蛋白的提取与鉴定[J].食品科学,2012,33(6):59-64. 被引量:25
  • 8宁志刚,王富友,崔运利,熊娟,杨柳.可溶性猪软骨Ⅱ型胶原蛋白的提取与鉴定[J].重庆医学,2011,40(10):954-955. 被引量:15
  • 9Yang L, Anderson D E, Baecher-Allan C, et al. IL-21 and TGF-beta are requiredfor differentiation of human T (H) 17 cells [J]. Nature, 2008, 454:350-352.
  • 10Manel N, Unutmaz D, Littman D R. Thedifferentiation of humanT(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor gammar [J]. Nat Immtmol, 2008, 9:641-649.

二级参考文献88

共引文献148

同被引文献55

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部